|
PARN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.131800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.716400E-01 |
| Normal-vs-Stage2 |
3.941200E-01 |
| Normal-vs-Stage3 |
4.259000E-01 |
| Normal-vs-Stage4 |
7.049800E-01 |
| Stage1-vs-Stage2 |
6.456800E-01 |
| Stage1-vs-Stage3 |
2.131800E-01 |
| Stage1-vs-Stage4 |
9.855800E-01 |
| Stage2-vs-Stage3 |
1.858020E-01 |
| Stage2-vs-Stage4 |
6.632400E-01 |
| Stage3-vs-Stage4 |
3.614000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.035000E-01 |
| Normal-vs-AfricanAmerican |
6.971000E-01 |
| Normal-vs-Asian |
7.309400E-01 |
| Caucasian-vs-AfricanAmerican |
7.968000E-01 |
| Caucasian-vs-Asian |
5.607600E-01 |
| AfricanAmerican-vs-Asian |
5.220800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.345700E-02 |
| Normal-vs-Female |
7.104200E-01 |
| Male-vs-Female |
2.259900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.805600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.669000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.477200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.477200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.759800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.804200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.173800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.917400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.886800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.811210E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.576300E-02 |
| Classical-VS-Follicular |
5.950000E-01 |
| Classical-VS-Other |
5.495400E-01 |
| Classical-VS-Normal |
5.059600E-01 |
| Tall-VS-Follicular |
4.114000E-02 |
| Tall-VS-Other |
3.393000E-01 |
| Tall-VS-Normal |
1.162830E-01 |
| Follicular-VS-Other |
6.104000E-01 |
| Follicular-VS-Normal |
3.619200E-01 |
| Other-VS-Normal |
5.036200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.670400E-01 |
| Normal-vs-N1 |
1.146970E-01 |
| N0-vs-N1 |
8.075800E-02 |
|
|
